How to cure the incurable with cell and gene therapy

At the forefront of cell and gene therapy advancements, SelectScience^® is thrilled to announce the launch of an exciting editorial feature: How to cure the incurable with cell and gene therapy. This interactive initiative sees leaders across industry and academia showcase the cutting-edge technologies that drive breakthroughs in the field.

The feature covers four pivotal topics:

1. How gene editing heralds new therapeutic era

Explore the powerful gene editing technologies and next generation of tools, from CRISPR and TALENs to ZFNs and beyond.

2. Breakthrough therapies to transform healthcare

Discover revolutionary treatments and new therapeutic options, including the recent approval of Casgevy™ and Lyfgenia™ for the treatment of sickle cell disease.

3. Innovative gene delivery for targeted therapeutics

Compare the available gene delivery systems for your therapeutics and evaluate the advantages of viral versus non-viral vectors for safe and efficacious therapy delivery.

4. Who are the innovators of future cell and gene therapies and personalized medicine?

Find out how experts are bringing the promise of customized medicine to life and discover the key players in an industry that is shaping the future of cell and gene therapy through innovative technology.

Engage with experts leading the way in cell and gene therapy

SelectScience is also excited to deliver a unique Accelerating Science Forum, a real-time online event where you will have the chance to speak to experts at the forefront of cell and gene therapy, discussing the road to progress, the latest advances, and what the future holds. The forum will be held in February 2024 and will bring together the ideas and topics raised by the Accelerating Science Feature, creating a dynamic platform for knowledge exchange.

“As we mark 25 years at the forefront of science communication, it feels like the perfect time to honor the remarkable achievements of scientists and manufacturers worldwide and look ahead at how we can work together to keep driving science forward in progressive and creative ways," said Kerry Parker, CEO of SelectScience. “We’d like to thank all our guests for joining us for this celebration of science and we can’t wait to share it with our community of scientists across the world.”

Join us on this captivating journey, exploring the limitless potential of cell and gene therapy.